- Home
- LGCL vs INMB Comparison
LGCL vs INMB Comparison
Compare LGCL & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- INMB
- Stock Information
- Founded
- LGCL 2009
- INMB 2015
- Country
- LGCL China
- INMB United States
- Employees
- LGCL N/A
- INMB N/A
- Industry
- LGCL
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- LGCL
- INMB Health Care
- Exchange
- LGCL NYSE
- INMB Nasdaq
- Market Cap
- LGCL 101.0M
- INMB 109.9M
- IPO Year
- LGCL 2024
- INMB 2019
- Fundamental
- Price
- LGCL $1.00
- INMB $4.56
- Analyst Decision
- LGCL
- INMB Strong Buy
- Analyst Count
- LGCL 0
- INMB 2
- Target Price
- LGCL N/A
- INMB $21.00
- AVG Volume (30 Days)
- LGCL 160.5K
- INMB 261.5K
- Earning Date
- LGCL 11-22-2024
- INMB 10-31-2024
- Dividend Yield
- LGCL N/A
- INMB N/A
- EPS Growth
- LGCL 11.49
- INMB N/A
- EPS
- LGCL 0.14
- INMB N/A
- Revenue
- LGCL $173,306,912.00
- INMB $42,000.00
- Revenue This Year
- LGCL N/A
- INMB N/A
- Revenue Next Year
- LGCL N/A
- INMB N/A
- P/E Ratio
- LGCL $7.57
- INMB N/A
- Revenue Growth
- LGCL N/A
- INMB N/A
- 52 Week Low
- LGCL $0.96
- INMB $4.47
- 52 Week High
- LGCL $5.00
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- INMB 31.87
- Support Level
- LGCL N/A
- INMB $6.09
- Resistance Level
- LGCL N/A
- INMB $6.26
- Average True Range (ATR)
- LGCL 0.00
- INMB 0.32
- MACD
- LGCL 0.00
- INMB -0.18
- Stochastic Oscillator
- LGCL 0.00
- INMB 4.25
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.